© Copyright Acquisition International 2025 - All Rights Reserved.

Article Image - Shining The Light On A Medical Marvel
Posted 18th December 2019

Shining The Light On A Medical Marvel

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

Mouse Scroll AnimationScroll to keep reading

Let us help promote your business to a wider following.

Shining The Light On A Medical Marvel
Advanced Oncotherapy

The fight against cancer has become one of the greatest in modern medical history, and scientific research continues to yield new medical methods for combating this disease. At the forefront of developing innovative technologies is Advanced Oncotherapy, a UK-based company focused on delivering proton-based radiotherapy. Heading into a new decade of medical advancement, discover why CEO Nicolas Serandour is being featured as one of Acquisition International’s CEOs to Watch in 2020.

In 2019 alone, nearly nine million people will have died of cancer. If left unchecked, that figure could well rise to over thirteen million every year by 2030. That is a staggering 1,500 deaths per hour. With these statistics in mind, breakthrough technologies represent one of the greatest hopes for cancer patients of both the present and future. Innovative CEOs such as Nicolas Serandour are standing steadfast as medical vanguards, relentlessly pursuing start-of-the-art technologies that can be leveraged in the ongoing fight against cancer.

Conventional treatments for cancer patients include radiation therapy, which is used in up to sixty percent of cases. However, it can come with costly side effects for the patients. Healthy tissue can suffer, causing internal damage that is hard to repair. That’s where Advanced Oncotherapy’s ground-breaking solution comes in. Focused on proton therapy, also known as proton beam therapy, Nicolas has spearheaded a venture that he believes will revolutionise the way physicians treat cancer moving forward. What separates proton therapy from traditional radiation therapy is the ability to target cancerous cells in the body without causing significant damage to the surrounding healthy tissue.
Advanced Oncotherapy’s vision for the future is one where a more affordable, proton-based radiotherapy system saves the lives of countless more cancer patients than ever before. With this innovative new technology proving to be both cost-effective and clinically superior to existing systems, Nicolas wants to make this vision a reality. Since being at the firm, Nicolas has overseen the development of its proprietary proton-based technology, LIGHT®.

Developed in collaboration with the world-renowned CERN in Switzerland, LIGHT® represents the next step in proton beam therapy and particle acceleration that will change the way cancer is approached. LIGHT®’s compact design allows the delivery of proton beams onto a tumour with greater precision, even during organ movement. This is due to LIGHT®’s capability to change the dose and energy very quickly, which is important for an entire class of moving tumours (lung, pancreatic, liver).

Nicolas and his team are also capitalising on LIGHT®’s uniquely small beam size to position the device ahead in the race for delivering what is called “FLASH”: a faster, cheaper approach to proton therapy. A research collaboration with the Cleveland Clinic, that will evaluate the target conformity of proton minibeams, is a significant development as it marks a clear endorsement from one of the most prestigious healthcare institutions in the world.

“Advanced Oncotherapy’s vision for the future is to save the lives of countless more cancer patients than ever before.”

The company has many ongoing discussions and exclusivity arrangements across the world, including great interest from China. Rather than simply boast about a new piece of tech, and expect hospitals to buy it, Nicolas has instead focused on building relationships that are clinically beneficial for all involved. By enabling hospitals to be a part of developing this new particle accelerator and investigating its therapeutic uses, Advanced Oncotherapy and LIGHT® have rapidly become compelling partners.

Nicolas’ success as CEO of Advanced Oncotherapy will soon see the first LIGHT® system implemented in Harley Street, London. An iconic medical location, this latest development sees yet another success secured for Nicolas and his team. As a proton beam accelerator that is far more compact that traditional radiology equipment, LIGHT® being implemented in the basement of two terraced houses in London will hopefully prove that it can be implemented almost anywhere.

Of course, the mark of any great CEO is the ability to recognise the incredible work of the team around them. Since the beginning of his tenure with Advanced Oncotherapy, Nicolas has remained indebted to the outstanding work and devotion of his staff in pursuing their one goal together; to save lives. Nicolas instils in his staff the energy and desire to work collectively as a team in meeting technical milestones set almost thirty months ago. Hiring and partnering with high-calibre experts in radiation and proton therapy, the team Nicolas has built is as much a testament to his success as that of LIGHT® itself.

For Nicolas, the next step is getting LIGHT® into hospitals where it can truly change lives for the better. A well-considered implementation plan is already in place to successfully transform Advanced Oncotherapy into the undisputed commercial leader for proton-based therapy. As the next decade beckons, while Nicolas remains one of the most exciting leaders to watch within oncotherapy, it is his firm’s potential to radically advance humanity’s efforts to defeat cancer for good that is the real draw.

Company: Advanced Oncotherapy
Contact: [email protected]
Website: https://www.avoplc.com/

Categories: Innovation, Leadership, Strategy


You Might Also Like
Read Full PostRead - Eye Icon
Things You Should Know If Someone Gets in an Accident With Your Car
Legal
27/06/2023Things You Should Know If Someone Gets in an Accident With Your Car

Lending your car to someone can be a stressful experience. Not only are they entrusted with something that cost quite a bit of money, but they’re also in possession of something that could potentially cause them and others extensive damage should an accident

Read Full PostRead - Eye Icon
Placing Ethical and Human Values at the Heart of all Relationships
Legal
30/08/2019Placing Ethical and Human Values at the Heart of all Relationships

UrbanLaw Avocats provides legal advice and assistance to public entities (national or local), as well as major French and international groups. Following their success in AI’s Global Excellence Awards 2019 where they were selected as the Best Urban Planning

Read Full PostRead - Eye Icon
Swiss Excellence in Business Aviation
Innovation
10/11/2017Swiss Excellence in Business Aviation

Swiss Excellence in Business Aviation

Read Full PostRead - Eye Icon
Navigating Dutch Business Culture: Advice for Expanding Your Business Operations to the Netherlands
Corporate Social Responsibility
23/05/2023Navigating Dutch Business Culture: Advice for Expanding Your Business Operations to the Netherlands

Around 400 companies each year set up their Business in the Netherlands, coming from Europe, North and South America, and Asia - and continues to be a place of choice for business expansion.

Read Full PostRead - Eye Icon
Why Your Company Needs an Asset Management Strategy
News
09/08/2021Why Your Company Needs an Asset Management Strategy

Asset management involves the development, operation, maintenance, and sale of assets efficiently and cost-effectively. All companies need to keep tabs on their assets to allow managers to know where and when to employ different assets to maximise returns. Add

Read Full PostRead - Eye Icon
The Exciting World of Mobile Trading
Innovation
07/06/2017The Exciting World of Mobile Trading

ThinkMarkets is an industry leader with a global presence — with headquarters in London and Melbourne as well as hubs in the AsiaPacific, Middle East & North Africa, Europe and South America.

Read Full PostRead - Eye Icon
National Journal Heartland Monitor Poll Finds Younger Generations Are Redefining Path to Success
Leadership
13/07/2015National Journal Heartland Monitor Poll Finds Younger Generations Are Redefining Path to Success

Most Americans believe it’s harder to get started today compared to previous generations.

Read Full PostRead - Eye Icon
4 Essential Components of Power Plant Maintenance
Innovation
25/11/20214 Essential Components of Power Plant Maintenance

Power plant maintenance aims at supporting a smooth workflow in a power plant. It involves procedures such as routine inspection, equipment adjustment, repair or replacement, and general systems integration and monitoring.

Read Full PostRead - Eye Icon
The Top 5 Trends in Glass Packaging for Skincare: A Sustainable Future
News
02/01/2025The Top 5 Trends in Glass Packaging for Skincare: A Sustainable Future

The skincare industry is undergoing a transformation, driven by a growing awareness of sustainability and eco-friendliness. One of the most notable changes is the shift towards glass packaging. In this article, we discuss the top five trends in glass packaging



Our Trusted Brands

Acquisition International is a flagship brand of AI Global Media. AI Global Media is a B2B enterprise and are committed to creating engaging content allowing businesses to market their services to a larger global audience. We have 14 unique brands, each of which serves a specific industry or region. Each brand covers the latest news in its sector and publishes a digital magazine and newsletter which is read by a global audience.

Arrow